Orchid Chemicals & Pharmaceuticals has completed the transaction for sale and
transfer of its generic injectable finished dosage forms pharmaceuticals
business to Hospira Healthcare India.
The company had entered into a business transfer agreement on 15 December
2009, to sell its injectable business to Hospira for $400 million (approx Rs
1,860 crore). The transaction includes Orchid's betalactam antibiotics
injectables manufacturing complex and formulations R&D facility at
Irungattukottai, Chennai.